Mycobacterial HSP70 as an adjuvant in the design of an idiotype vaccine against a murine lymphoma

Cellular Immunology
Lavakumar Karyampudi, Swapan K Ghosh

Abstract

Mycobacterial HSP70 protein coupled with ovalbumin is known to elicit antigen-specific CD8(+) T-cell response. We investigated whether anti-idiotype immunity can likewise be enhanced using a conjugate of recombinant mycHSP70 and the Ig Id in a murine lymphoma model, A20. Plasmids were constructed of A20 tumor to generate A20Id-HSP70 (scFv-H), unconjugated A20Id (scFv), and mycHSP70 (H) recombinant proteins. We evaluated their relative efficacy in activating anti-tumor immunity that can reduce the mortality of tumor-challenged BALB/c mice; significantly, a longer term protection (>50% of the population) was observed in mice vaccinated with scFv-H compared to those receiving the scFv or H proteins. Concomitantly a much higher-level activation in anti-A20 cytotoxic T-cell activity, IFN-gamma secretion and predominantly anti-A20 IgG2a response was also observed with the scFv-H group. Thus, conjugating HSP70 with the A20Id renders the latter significantly immunogenic and affords longer protection against A20 tumor progression.

References

Jan 1, 1989·International Reviews of Immunology·A J George, F K Stevenson
Jun 27, 1985·The New England Journal of Medicine·T MeekerR Levy
Jun 1, 1995·Immunological Reviews·F K StevensonR E Hawkins
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·K SuzueR A Young
Feb 28, 2002·Trends in Immunology·Robert P A WallinHans-Gustaf Ljunggren
Dec 30, 2003·International Journal of Cancer. Journal International Du Cancer·Hsing-I HuangMi-Hua Tao
Sep 11, 2004·Biochemical and Biophysical Research Communications·Nisreen Al-Shaibi, Swapan K Ghosh
Dec 30, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Giorgio ParmianiMario Santinami
Jan 18, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Agnete B FredriksenBjarne Bogen
Apr 22, 2008·British Journal of Haematology·Hyun Jun Park, Sattva S Neelapu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.